TinyGemsBreaks Archive - Page 2 of 146

ThursdayApr 23, 2026 9:50 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Expands European Presence With Romania Reseller Agreement

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a reseller agreement with Romania-based New Akord Security to market its DefendAir counter-drone system and provide training and local support, expanding its footprint across Europe and NATO-aligned markets. The agreement includes an initial demo kit purchase and planned live demonstration for Romanian defense officials at the BSDA exhibition in Bucharest, as the company builds momentum for its non-kinetic drone interception technology designed to protect military and civilian infrastructure. To view the full press release, visit https://ibn.fm/k6jKZ About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for…

FridayApr 17, 2026 2:14 pm

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article. “Rail Vision’s AI-powered electro-optical sensor systems are designed to address key railway safety challenges by integrating wide-field and narrow-field electro-optic cameras to provide a complete ‘safety envelope’ around the train. The company’s solutions include the use of thermal cameras that…

FridayApr 17, 2026 1:27 pm

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear…

ThursdayApr 16, 2026 9:10 am

TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Ken Kramer SVP Medical Affairs

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists (“NSAs”), announced the appointment of Dr. Ken Kramer, PhD, as senior vice president of medical affairs, effective immediately. Kramer brings more than 20 years of neuroscience-focused medical affairs leadership, including roles at Bristol Myers Squibb, Karuna Therapeutics and AbbVie, and is expected to support Helus in advancing its pipeline and strengthening engagement with clinical and scientific stakeholders. To view the full press release, visit https://ibn.fm/FdEXH About Helus Pharma Helus Pharma(TM),…

WednesdayApr 15, 2026 9:55 am

TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Publication of TONMYA Pharmacokinetic Study in Peer-Reviewed Journal

Tonix Pharmaceuticals (NASDAQ: TNXP), a commercial-stage biotechnology company, announced the publication of a peer-reviewed study detailing the steady-state pharmacokinetic properties of TNX-102 SL, the sublingual formulation of cyclobenzaprine HCl marketed as TONMYA(R), in Clinical Pharmacology in Drug Development. The study, conducted in 60 healthy volunteers, demonstrated that the sublingual formulation achieves faster absorption, earlier peak plasma concentration and higher dose-normalized bioavailability compared to oral extended-release cyclobenzaprine, supporting its use for long-term bedtime dosing to target nonrestorative sleep in fibromyalgia, reduce pain and improve related symptoms. To view the full press release, visit https://ibn.fm/AX1hL Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is…

TuesdayApr 14, 2026 9:20 am

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Secures $400K in New IoT Orders, Builds on Growing Military and Enterprise Demand

NextPlat (NASDAQ: NXPL, NXPLW) reported that its Global Telesat Communications Ltd subsidiary has received approximately $400,000 in new orders for satellite-enabled IoT hardware, supporting an existing military end-user in Eastern Europe and a new customer in Asia, as demand from providers including Globalstar and Iridium continues to grow. The orders follow a recent $820,000 contract tied to a NATO military customer, bringing total IoT-related orders secured in the first quarter of 2026 to more than $1.2 million, reflecting expanding momentum in government, defense and enterprise connectivity markets alongside anticipated growth from the company’s expanding healthcare operations, according to CEO David…

MondayApr 13, 2026 9:00 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Repeat Defense Order for DefendAir CUAS System

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company specializing in autonomous solutions for manned and unmanned aerial systems, announced it has received a second purchase order from a defense entity for its DefendAir Counter-Unmanned Aerial Systems solution following prior evaluation and training. The order includes Personal Net Launchers, net pods and a comprehensive training package designed to support rapid deployment and operational readiness, reinforcing ParaZero’s growing presence with defense partners and highlighting demand for its non-kinetic, multi-layered drone interception technology, which has demonstrated 100% success in field trials and supports flexible configurations for urban, battlefield and infrastructure protection. To view…

ThursdayApr 09, 2026 9:40 am

TinyGemsBreaks – Frontieras North America CEO Matthew T. McKean Frames Mason County Groundbreaking as Launch of New U.S. Energy Industry

Blog emphasizes execution, scale and antifragile model as company advances first commercial FASForm deployment Frontieras North America CEO Matthew T. McKean, in a recent blog, positions the company’s Mason County, West Virginia, groundbreaking as more than a project milestone—describing it as the foundation of a new domestic energy industry built on its patented FASForm technology. Writing in the context of historic global energy disruption, McKean underscores the structural fragility of crude-dependent systems while highlighting Frontieras’ differentiated model, which pairs long-term, fixed-cost coal feedstock with outputs priced against global commodity markets. The blog details the company’s rapid execution from site acquisition…

WednesdayApr 08, 2026 10:00 am

TinyGemsBreaks – Frontieras North America Highlights Antifragile Energy Strategy as Global Markets Face Historic Disruption

CEO Matthew T. McKean outlines Mason County as proof point for scalable, domestically sourced energy model built to benefit from volatility Frontieras North America CEO Matthew T. McKean, in a newly released blog, details how recent global energy disruptions have exposed the structural weakness of crude-dependent systems while reinforcing the need for a more resilient—and antifragile—approach to energy production. As volatility drives sharp increases in diesel, naphtha and fertilizer prices, McKean emphasizes that the company’s FASForm platform is designed with a fundamentally different architecture: low, fixed-cost domestic coal feedstock paired with outputs priced against global markets, allowing revenues to rise even…

MondayApr 06, 2026 9:30 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Follow-On DefendAir Counter-Drone Order From Israeli Defense Entity

ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional purchase order from an Israeli defense entity for its DefendAir counter-unmanned aerial systems, representing a follow-on order under an existing direct contract as demand rises amid escalating drone threats in modern conflicts. The company said its multi-layered, soft-kill DefendAir system uses patented net-launching technology to safely intercept hostile drones with minimal collateral damage, having demonstrated 100% interception success in field trials, and is designed to protect troops, infrastructure and urban environments while supporting expanded deployment across defense operations. To view the full press release, visit https://ibn.fm/MD995 About ParaZero Technologies ParaZero Technologies Ltd.…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks